BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15203092)

  • 21. [Pediatric cardiology in the genomic era].
    Marín-García J
    Rev Esp Cardiol; 2004 Apr; 57(4):331-46. PubMed ID: 15104988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.
    Piana C; Surh L; Furst-Recktenwald S; Iolascon A; Jacqz-Aigrain EM; Jonker I; Russo R; van Schaik RH; Wessels J; Della Pasqua OE
    J Clin Pharmacol; 2012 May; 52(5):704-16. PubMed ID: 21566202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential of pharmacogenetics in the treatment of epilepsy.
    Depondt C
    Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT40-2. PubMed ID: 11221715
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug discovery and development in the age of molecular medicine.
    Vallance P; Levick M
    Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bridging the knowledge gaps in vaccine design.
    Rappuoli R
    Nat Biotechnol; 2007 Dec; 25(12):1361-6. PubMed ID: 18066025
    [No Abstract]   [Full Text] [Related]  

  • 29. The challenges of delivering pharmacogenomics into clinical pediatrics.
    Leeder JS; Kearns GL
    Pharmacogenomics J; 2002; 2(3):141-3. PubMed ID: 12082583
    [No Abstract]   [Full Text] [Related]  

  • 30. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective.
    Lesko LJ; Woodcock J
    Nat Rev Drug Discov; 2004 Sep; 3(9):763-9. PubMed ID: 15340386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic medicine: bringing biomarkers to clinical medicine.
    Seo D; Ginsburg GS
    Curr Opin Chem Biol; 2005 Aug; 9(4):381-6. PubMed ID: 16006183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomics and the future of pharmacotherapy in psychiatry.
    Malhotra AK; Lencz T; Correll CU; Kane JM
    Int Rev Psychiatry; 2007 Oct; 19(5):523-30. PubMed ID: 17896232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric perspective on pharmacogenomics.
    Stevens A; De Leonibus C; Hanson D; Whatmore A; Murray P; Donn R; Meyer S; Chatelain P; Clayton P
    Pharmacogenomics; 2013 Nov; 14(15):1889-905. PubMed ID: 24236488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomics and its implications for autoimmune disease.
    Ross CJ; Katzov H; Carleton B; Hayden MR
    J Autoimmun; 2007; 28(2-3):122-8. PubMed ID: 17418528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics/genomics and personalized medicine.
    Sadée W; Dai Z
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genomics and Personalized Medicine Act of 2006.
    Obama B
    Clin Adv Hematol Oncol; 2007 Jan; 5(1):39-40. PubMed ID: 17339825
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacogenetics in Europe: barriers and opportunities.
    Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D
    Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.
    Ross CJ; Carleton B; Warn DG; Stenton SB; Rassekh SR; Hayden MR
    Ann N Y Acad Sci; 2007 Sep; 1110():177-92. PubMed ID: 17911433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.